Anixa Financial Statements From 2010 to 2024

Stocks . USA . 
Stock . Anixa Biosciences
ANIX Stock  USD 3.30  0.01  0.30%   
Anixa Biosciences financial statements provide useful quarterly and yearly information to potential Anixa Biosciences investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Anixa Biosciences financial statements helps investors assess Anixa Biosciences' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Anixa Biosciences' valuation are summarized below:
Gross Profit
127.5 K
Market Capitalization
106.2 M
Enterprise Value Revenue
368.9827
Earnings Share
(0.39)
We have found one hundred twenty available fundamental signals for Anixa Biosciences, which can be analyzed and compared to other ratios and to its rivals. All investors should make sure to validate all of Anixa Biosciences prevailing market performance against the performance between 2010 and 2024 to make sure the company can sustain itself down the road. Enterprise Value is likely to rise to about 134.2 M in 2024, whereas Market Cap is likely to drop slightly above 140.1 M in 2024.

Anixa Biosciences Total Revenue

229,425

Check Anixa Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Anixa Biosciences' main balance sheet or income statement drivers, such as Interest Expense of 216.9 K, Selling General Administrative of 4.2 M or Total Revenue of 229.4 K, as well as many indicators such as Price To Sales Ratio of 861, Dividend Yield of 0.0 or PTB Ratio of 4.39. Anixa financial statements analysis is a perfect complement when working with Anixa Biosciences Valuation or Volatility modules.
  
Check out the analysis of Anixa Biosciences Correlation against competitors.
For more information on how to buy Anixa Stock please use our How to Invest in Anixa Biosciences guide.

Anixa Biosciences Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets30.8 M29.4 M14.8 M
Slightly volatile
Other Current Liabilities2.1 M2 M944.5 K
Slightly volatile
Total Current Liabilities2.4 M2.3 M1.5 M
Slightly volatile
Property Plant And Equipment Net132.1 K149.4 K121.6 K
Slightly volatile
Cash999.6 K1.1 M5 M
Pretty Stable
Non Current Assets Total181.4 K190.9 K1.4 M
Slightly volatile
Cash And Short Term Investments28.8 M27.4 M12.8 M
Slightly volatile
Common Stock Shares Outstanding37.4 M35.6 M18.7 M
Slightly volatile
Liabilities And Stockholders Equity30.8 M29.4 M14.8 M
Slightly volatile
Other Current Assets1.2 M1.1 M586.3 K
Slightly volatile
Other Stockholder Equity304.6 M290.1 M185.1 M
Slightly volatile
Total Liabilities2.2 M2.5 M3 M
Slightly volatile
Property Plant And Equipment Gross132.1 K149.4 K121.6 K
Slightly volatile
Total Current Assets30.6 M29.2 M13.4 M
Slightly volatile
Net Receivables231.6 K243 K312.2 K
Slightly volatile
Accounts Payable176.1 K185.4 K344.3 K
Slightly volatile
Non Current Liabilities Total134.4 K141.4 K1.6 M
Slightly volatile
Common Stock Total Equity264.2 K278.1 K612.3 K
Slightly volatile
Short Term Investments27.7 M26.4 M8 M
Slightly volatile
Common Stock265.9 K279.9 K612.1 K
Slightly volatile
Property Plant Equipment256 K243.8 K137.2 K
Slightly volatile
Current Deferred Revenue1.3 M1.4 M1.2 M
Very volatile
Short and Long Term Debt Total149.6 K157.5 K1.6 M
Slightly volatile
Other Liabilities3.2 M4.8 M3.7 M
Slightly volatile
Capital Surpluse181.1 M284.2 M184.7 M
Slightly volatile
Long Term Investments3.8 M3.8 M4.3 M
Slightly volatile
Non Current Liabilities Other149.6 K157.5 K1.8 M
Slightly volatile
Long Term Debt Total319.5 K630.9 K470 K
Slightly volatile
Short Term Debt44.5 K46.8 K263.8 K
Slightly volatile
Net Invested Capital18.3 M28 M14 M
Slightly volatile
Net Working Capital17.2 M26.8 M12.7 M
Slightly volatile
Capital Stock285.2 K357.6 K234.8 K
Slightly volatile
Capital Lease Obligations195.4 K201.2 K106.9 K
Slightly volatile

Anixa Biosciences Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Selling General Administrative4.2 M7.2 M5.5 M
Slightly volatile
Other Operating Expenses6.9 M12.9 M9.4 M
Slightly volatile
Total Operating Expenses6.6 M12.7 M8.8 M
Slightly volatile
Depreciation And Amortization50.3 K52.9 K203.8 K
Pretty Stable
Research Development3.6 M5.5 M3.6 M
Slightly volatile
Interest Income1.3 M1.2 M406 K
Slightly volatile
Reconciled Depreciation39.3 K41.4 K247.2 K
Slightly volatile

Anixa Biosciences Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow14.9 M14.2 M6.7 M
Slightly volatile
Depreciation50.3 K52.9 K241.1 K
Slightly volatile
End Period Cash Flow999.6 K1.1 M5 M
Pretty Stable
Stock Based Compensation4.3 M5.1 M4.2 M
Slightly volatile
Change To Netincome3.9 M7.7 M4 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio861536238
Slightly volatile
Dividend Yield0.00.01.0E-4
Slightly volatile
Days Sales Outstanding443422251
Slightly volatile
Average Payables557.4 K470.5 K519.8 K
Slightly volatile
Stock Based Compensation To Revenue19.918.959.5138
Slightly volatile
Capex To Depreciation0.190.20.2556
Slightly volatile
EV To Sales835532227
Slightly volatile
Sales General And Administrative To Revenue28.3126.9612.792
Slightly volatile
Research And Ddevelopement To Revenue21.4620.448.6514
Slightly volatile
Capex To Revenue0.660.630.3625
Slightly volatile
Cash Per Share1.380.890.7058
Pretty Stable
Intangibles To Total Assets0.280.150.2156
Slightly volatile
Current Ratio5.9411.258.391
Slightly volatile
Receivables Turnover0.670.72.4268
Slightly volatile
Graham Number2.582.722.6937
Pretty Stable
Capex Per Share8.0E-48.0E-40.0062
Slightly volatile
Average Receivables1.2 K1.3 K92 K
Slightly volatile
Revenue Per Share0.00580.00615.5459
Pretty Stable
Interest Debt Per Share0.00540.00570.1726
Slightly volatile
Debt To Assets0.00170.00170.175
Slightly volatile
Ebt Per Ebit0.880.811.0765
Slightly volatile
Long Term Debt To Capitalization1.212.242.1932
Pretty Stable
Total Debt To Capitalization0.00170.00180.3064
Slightly volatile
Quick Ratio5.8211.259.2384
Slightly volatile
Net Income Per E B T1.11.141.0116
Slightly volatile
Cash Ratio0.490.525.3247
Pretty Stable
Days Of Sales Outstanding443422251
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.121.151.0268
Slightly volatile
Fixed Asset Turnover1.081.14823
Pretty Stable
Debt Ratio0.00170.00170.175
Slightly volatile
Price Sales Ratio861536238
Slightly volatile
Asset Turnover0.0070.00745.5512
Pretty Stable
Gross Profit Margin0.250.270.4542
Slightly volatile

Anixa Biosciences Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap140.1 M167.3 M84 M
Slightly volatile
Enterprise Value134.2 M134.1 M73.3 M
Slightly volatile

Anixa Fundamental Market Drivers

Cash And Short Term Investments23.8 M

Anixa Upcoming Events

21st of March 2024
Upcoming Quarterly Report
View
12th of June 2024
Next Financial Report
View
31st of January 2024
Next Fiscal Quarter End
View
21st of January 2025
Next Fiscal Year End
View
31st of October 2023
Last Quarter Report
View
31st of October 2023
Last Financial Announcement
View

About Anixa Biosciences Financial Statements

Anixa Biosciences investors use historical fundamental indicators, such as Anixa Biosciences' revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Anixa Biosciences. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue1.4 M1.3 M
Total Revenue241.5 K229.4 K
Cost Of Revenue185.2 K175.9 K
Stock Based Compensation To Revenue 18.95  19.90 
Sales General And Administrative To Revenue 26.96  28.31 
Research And Ddevelopement To Revenue 20.44  21.46 
Capex To Revenue 0.63  0.66 
Revenue Per Share 0.01  0.01 
Ebit Per Revenue(60.30)(57.28)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
VVisa Class A
GOOGAlphabet Inc Class C
GOOGAlphabet Inc Class C

Additional Tools for Anixa Stock Analysis

When running Anixa Biosciences' price analysis, check to measure Anixa Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Anixa Biosciences is operating at the current time. Most of Anixa Biosciences' value examination focuses on studying past and present price action to predict the probability of Anixa Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Anixa Biosciences' price. Additionally, you may evaluate how the addition of Anixa Biosciences to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY